Clinical Trials
All Clinical Trials - Page 38 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03130426Phase 3Completed
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
Lixisenatide
- NCT03204396Phase 2Completed
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
Dulaglutide
- NCT03035032Phase 4Completed
A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients
Gonadorelin
- NCT03115424Phase 3Completed
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Liraglutide
- NCT02949284Phase 2Active Not Recruiting
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
Gonadorelin
- NCT02824718Phase 2Completed
Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
Teriparatide
- NCT03881904Phase 1/Phase 2Unknown
OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol
Gonadorelin
- NCT03353883Phase 2/Phase 3Unknown
Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?
Gonadorelin
- NCT03115099Phase 1Completed
A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
Liraglutide
- NCT03172494Phase 3Completed
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Liraglutide
- NCT03175120Phase 3Completed
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
Liraglutide
- NCT03131687Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Tirzepatide
- NCT03167411Phase 1Completed
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Exenatide
- NCT03048578Phase 4Completed
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Liraglutide
- NCT03007732Phase 2Completed
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Gonadorelin
- NCT02803918Phase 1Completed
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Lixisenatide
- NCT03133195Phase 3Completed
The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA
Teriparatide
- NCT03001349EARLY_Phase 1Terminated
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
Octreotide
- NCT03000946Phase 3Completed
Prevention of Postoperative Pancreatic Fistula by Somatostatin
Octreotide
- NCT03012594Phase 2Completed
Lanreotide in the Treatment of Small Bowel Motility Disorders
Lanreotide
- NCT02960659Phase 1/Phase 2Completed
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
Liraglutide
- NCT03044977EARLY_Phase 1Active Not Recruiting
Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors
Octreotide
- NCT03072147Phase 2Completed
Teriparatide as a Chondroregenerative Therapy in OA
Teriparatide
- NCT02972424Phase 2Completed
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
Teriparatide
- NCT03158805Phase 2Completed
Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
Liraglutide
- NCT03017690N/ACompleted
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Octreotide
- NCT03082885N/ACompleted
The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF
Thymosin-Alpha-1
- NCT03112694N/ACompleted
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Octreotide
- NCT03824002Phase 4Completed
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
Dulaglutide
- NCT03103009Phase 1Completed
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
Octreotide
- NCT03136484Phase 3Completed
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
Semaglutide
- NCT03086330Phase 3Completed
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT03007329Phase 4Completed
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Exenatide
- NCT03009981Phase 3Completed
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Gonadorelin
- NCT02683941Phase 3Terminated
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
Lanreotide
- NCT02964247Phase 3Completed
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
Liraglutide
- NCT03060980Phase 3Terminated
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Exenatide
- NCT03169166Phase 4Completed
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies
Gonadorelin
- NCT03472846Phase 4Completed
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
Teriparatide
- NCT03071172Phase 3Unknown
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
Gonadorelin
- NCT03085966Phase 1/Phase 2Unknown
Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC
Gonadorelin
- NCT02941367Phase 4Completed
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
Lixisenatide
- NCT03043807Phase 2Completed
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Gonadorelin
- NCT04060043EARLY_Phase 1Completed
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
Gonadorelin
- NCT02735031Phase 2/Phase 3Completed
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Exenatide
- NCT02239523N/ACompleted
Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis
Teriparatide
- NCT03041792Phase 1Completed
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
Liraglutide
- NCT04296149Phase 2Completed
Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe
Octreotide
- NCT02572323Phase 2Completed
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Tesamorelin
- NCT02896192Phase 3Completed
Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity
Setmelanotide